These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 32043016)
1. A case of pentosan polysulfate maculopathy originally diagnosed as stargardt disease. Vora RA; Patel AP; Yang SS; Melles R Am J Ophthalmol Case Rep; 2020 Mar; 17():100604. PubMed ID: 32043016 [TBL] [Abstract][Full Text] [Related]
2. Case Report: Pentosan Polysulfate Sodium Maculopathy Originally Diagnosed as Pattern Macular Dystrophy. Case AW; Anderson MJ; Sayomac LE Optom Vis Sci; 2021 Jun; 98(6):552-556. PubMed ID: 34039907 [TBL] [Abstract][Full Text] [Related]
5. MACULAR HOLE IN A PATIENT WITH PENTOSAN POLYSULFATE MACULOPATHY. Arora N; Hoyek S; Patel NA Retin Cases Brief Rep; 2024 Sep; 18(5):544-548. PubMed ID: 37321232 [TBL] [Abstract][Full Text] [Related]
6. Age-Related Macular Degeneration Masquerade: A Review of Pentosan Polysulfate Maculopathy and Implications for Clinical Practice. Mukhopadhyay C; Boyce TM; Gehrs KM; Folk JC; Mullins RF; Luo Y; Kreder K; Sohn EH Asia Pac J Ophthalmol (Phila); 2022 Mar-Apr 01; 11(2):100-110. PubMed ID: 35533330 [TBL] [Abstract][Full Text] [Related]
7. Nationwide Usage of Pentosan Polysulfate and Practice Patterns of Pentosan Polysulfate Maculopathy Screening in South Korea. Kim J; Kwon HY; Kim JH; Ahn SJ Ophthalmol Retina; 2024 Mar; 8(3):246-253. PubMed ID: 37832716 [TBL] [Abstract][Full Text] [Related]
8. Cystoid Macular Edema Arising 10 Years After Cessation of Pentosan Polysulfate Sodium Successfully Treated With Bevacizumab. Szelog JT; Shah NS; Camejo MD J Vitreoretin Dis; 2023; 7(1):83-86. PubMed ID: 37008392 [TBL] [Abstract][Full Text] [Related]
9. Pentosan Polysulfate Maculopathy With 13 Years of Follow-up Imaging. Pinto AM; Jain N; Gupta RR J Vitreoretin Dis; 2024; 8(3):325-333. PubMed ID: 38770071 [No Abstract] [Full Text] [Related]
10. Prevalence and Dose Dependency Analysis of Pentosan Polysulfate Sodium Maculopathy. Philip AM; Wannamaker KW; Miller DM Ophthalmic Epidemiol; 2023 Feb; 30(1):82-87. PubMed ID: 35081852 [TBL] [Abstract][Full Text] [Related]
11. Type 3 macular neovascularization in a patient with pentosan polysulfate maculopathy. Bousquet E; Lee BA; Santina A; Sadda S; Sarraf D Am J Ophthalmol Case Rep; 2023 Mar; 29():101771. PubMed ID: 36561881 [TBL] [Abstract][Full Text] [Related]
12. POTENTIAL NEW-ONSET CLINICALLY DETECTABLE PENTOSAN POLYSULFATE MACULOPATHY YEARS AFTER DRUG CESSATION. Barnett JM; Jain N Retin Cases Brief Rep; 2022 Nov; 16(6):724-726. PubMed ID: 33229920 [TBL] [Abstract][Full Text] [Related]
15. An unusual case of rapid resolution of bilateral vitelliform deposits after discontinuation of pentosan polysulfate sodium. Kalaw FGP; Scott NL; Borooah S Am J Ophthalmol Case Rep; 2023 Dec; 32():101875. PubMed ID: 37645698 [TBL] [Abstract][Full Text] [Related]
16. Pentosan Polysulfate Sodium Exposure and Drug-Induced Maculopathy in Commercially Insured Patients in the United States. Ludwig CA; Vail D; Callaway NF; Pasricha MV; Moshfeghi DM Ophthalmology; 2020 Apr; 127(4):535-543. PubMed ID: 31899034 [TBL] [Abstract][Full Text] [Related]